- This event has passed.
Presenter(s): Gavin Bart, MD, PhD, Director, Division of Addiction Medicine at Hennepin Healthcare; Minneapolis, MN, Professor, Medical Discovery Team on Addiction at the University of Minnesota; Joan Kandel, DO, Physician, Bright Heart Health (telemedicine); Dulce, NM, Retired Family Medicine Physician, Indian Health Service - Navajo Nation and Jicarilla Apache Nation; Annie Potter, MSN, MPH, NP, CARN-AP, Clinical Educator, Office Based Addiction Treatment Program at Boston Medical Center and Boston University School of Medicine
Facilitator: Sherry Larkins, PhD, Director of International Programs and Research Sociologist, Integrated Substance Abuse Programs at the University of California, Los Angeles – Semel Institute for Neuroscience and Human Behavior
Cost: No fee
Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers.
Credit Designations Available: AMA PRA Category 1 Credit™, and Interprofessional Continuing Education (IPCE) credit.
Webinar Description: Once your clinical site leadership has demonstrated an interest in exploring buprenorphine or other pharmacotherapies as a treatment option for opioid use disorder (OUD) patients, and you have identified a champion to help lead the effort, what are the next steps? How can you ensure the broader clinical workforce is properly trained and confident in their ability to treat patients using pharmacotherapies? This session will review key clinical components of medications for addiction treatment (MAT), including buprenorphine treatment and its various formulations, clinic-wide implementation of new medications, and staff preparation, readiness and motivation. We will also review organizational capacity to access medication, properly screen and identify patients, and engage community partners and referral resources necessary to ensure OUD patients have access to a continuum of treatment and care services.
- Review specific buprenorphine formulations
- Prepare a site needs/asset assessment to identify facilitators and barriers to MAT implementation
- Review the training and certifications required for specific team members to implement MAT
- Illustrate skills to assess program readiness to implement MAT, and motivate staff toward adopting this evidenced based practice
Continuing Education Information:
In support of improving patient care, this activity has been planned and implemented by Addiction Technology Transfer Center Network and American Academy of Addiction Psychiatry. American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Interprofessional Continuing Education (IPCE) Designation Statement:
This activity was planned by and for the healthcare team, and learners will receive 1 (one) Interprofessional Continuing Education credits for learning and change.
Physician Designation Statement
American Academy of Addiction Psychiatry designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Health Professionals
Participants will receive a Certificate of Attendance stating this program is designated for 1.0 hour AMA PRA Category 1 Credit™. This credit is accepted by the AANP and the AAPA.